Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marsh & McLennan Companies, Inc. (MRSH) vs Synopsys, Inc. (SNPS) Price & Performance

Marsh & McLennan Companies, Inc.Trade
Synopsys, Inc.Trade

Price performance (Past 24H)

Key statistics

Marsh & McLennan Companies, Inc. vs Synopsys, Inc. — how do they compare? Marsh & McLennan Companies, Inc. trades at $175.94 (market cap $84.31B), while Synopsys, Inc. trades at $509.81 (market cap $95.39B). The key difference: Marsh & McLennan Companies, Inc. and Synopsys, Inc. are close in size by market cap, and Marsh & McLennan Companies, Inc. pays a 2.24% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marsh & McLennan Companies, Inc. for 109 Days and Synopsys, Inc. for 71 Days on average.

MRSHSNPS
Market Cap
$84.31B$95.39B
Volume
3,948,9473,374,903
Sector
FinancialsTechnology
52-Week High
$207.02$534.56
52-Week Low
$157.32$367.70
Typical Hold Time
109 Days71 Days
Enterprise Value
$104.99B$102.62B
Dividend Yield
2.24%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marsh & McLennan Companies, Inc.

MRSH trades at $176.16, up 1.44% today, with a bullish technical signal and consistent earnings beats in recent quarters. The company completed the acquisition of Accel Holdings on October 2, 2026, expanding its advisory footprint. Revenue grew to $27.0B in 2025, with a net income margin of 15.41%, while valuation ratios like P/E of 21.57 and ROE of 25.72% reflect strong profitability. Analysts maintain a consensus price target of $202.71, though sentiment is mixed with a 'Hold' rating from most.

The outlook for MRSH is positive due to earnings momentum and strategic acquisitions, but risks include competitive pressures and potential margin compression. Upside remains if the company meets Q3 2026 EPS expectations of $1.97, supported by solid cash flow trends. Investors should weigh the high P/B ratio of 5.55 against growth prospects in the reinsurance sector.

Synopsys, Inc.

Synopsys (SNPS) stock trades at $505.76, up 0.61% today, near its 52-week high. The technical picture is bullish with strong moving average support, though RSI levels suggest overbought conditions. Fundamentally, the company reported strong quarterly earnings beats and robust revenue growth, driven by AI partnerships with OpenAI and Amazon. Analyst sentiment is overwhelmingly positive with a 93% buy rating and a consensus price target of $572.54, indicating significant upside potential.

The outlook for SNPS is highly favorable, supported by AI-driven demand for chip design software and strategic acquisitions like Ansys. Key risks include high valuation multiples and integration challenges from recent deals. Investors should focus on execution of growth initiatives and monitor competitive pressures in the semiconductor design software market.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRSH
100% Buy0% Sell
Avg holding period · 109 Days
SNPS
33% Buy67% Sell
Avg holding period · 71 Days

Top news

Latest headlines on both assets

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH →

About Synopsys, Inc.

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Read more on SNPS →